Adell Harriman & Carpenter’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Adell Harriman & Carpenter's BIIB Position: Q2 2019 in Review
Adell Harriman & Carpenter sold out of Biogen (BIIB) in Q2 2019, closing a stake of 2,355 shares — an estimated $557K sold.
Adell Harriman & Carpenter first reported a position in BIIB in Q4 2014 and held it in 18 quarters. The position peaked at $2.76M in Q3 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.
- Adell Harriman & Carpenter reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
- Adell Harriman & Carpenter sold 2,355 Biogen shares in Q2 2019, an estimated $557K.
- Adell Harriman & Carpenter first reported a position in Biogen in Q4 2014 and held it in 18 quarters.
- Adell Harriman & Carpenter's Biogen position peaked at $2.76M in Q3 2016.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.
Based on Adell Harriman & Carpenter's 13F filing for Q2 2019, filed 7 Aug 2019.